Phase III clinical trial - Hématologie Lymphome non Hodgkinien

Hématologie Lymphome non Hodgkinien
Ouvert depuis le: 12.05.2023
Site: Saint-Cloud
Public cible
Phase III Trial Evaluating Maintenance Treatment Versus Observation in Elderly Patients Suffering From Primary Central Nervous System Lymphoma in Complete Remission After High Dose Methotrexate Based Chemotherapy in First Line
Description de l'essai
Our hypothesis is that maintenance chemotherapy will prolong complete remission obtained after a standard induction chemotherapy with an acceptable toxicity in the elderly.